Whistleblowers Lose 1st Circ. Appeal Of Novartis FCA Suit
The First Circuit refused Friday to revive a whistleblower suit accusing Novartis Pharmaceuticals Corp. and Genentech Inc. of off-label marketing and providing kickbacks to sell an asthma drug, although the court...To view the full article, register now.
Already a subscriber? Click here to view full article